Rare diseases in renal replacement therapy in the ERA-EDTA Registry

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 7, 1996, Pages 4-20

  Tsakiris, D ^a   Simpson, H K L ^a   Jones, E H P ^a   Briggs, J D ^a   Elinder, C G ^a   Mendel, S ^a   Piccoli, G ^a   Dos Santos, J P ^a   Tognoni, G ^a   Vanrenterghem, Y ^a   Valderrabano, F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CISPLATIN; CYCLOSPORIN; GLYCOSPHINGOLIPID; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; AGED; CACHEXIA; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DIALYSIS; FABRY DISEASE; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PARESTHESIA; PRIORITY JOURNAL; REGISTER; REVIEW; SCLERODERMA; SURVIVAL RATE;

EID: 12644253826     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp7.4     Document Type: Review

References (41)

1. Broyer M, Brunner FP, Brynger H et al. Demography of dialysis and transplantation in Europe, 1984. Nephrol Dial Transplant 1986; 1: 1-8
2. Stein VD. Renal involvement in systemic sclerosis. Clin Dermatol 1994; 12: 253-258
3. Medsger TA Jr. Treatment of systemic sclerosis. Ann Rheum Dis 1991; S50: S877-S886
4. Steen VD, Constantino JP, Shapiro AP, Medsger TA Jr. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 1990; 113: 352-357
5. Richardson JA. Haemodialysis and renal transplantation in progressive systemic sclerosis. Arthritis Rheum 1973; 16: 265-271
6. Keane WF, Danielson B, Ray L. Successful renal transplantation in progressive systemic sclerosis. Ann Intern Med 1976; 85: 199-202
7. McKinney TD, McAllister CJ, Stone WJ, Johnson HK, Ginn HE. Haemodialysis and renal transplantation in progressive systemic sclerosis. Report of 2 cases. Clin Nephrol 1979; 12: 178-185
8. Copley JB, Smith BJ. Continuous ambulatory peritoneal dialysis and scleroderma. Nephron 1985; 40: 353-356
9. LeRoy EC, Fleischmann RM. The management of renal scleroderma: experience with dialysis, nephrectomy and transplantation. Am J Med 1978; 64: 974-978
10. Nissenson AR, Port FK. Outcome of end-stage renal disease in patients with rare causes of renal failure. III. Systemic/vascular disorders. Q J Med 1990; 74: 63-74
11. Hill J, Speer RJ, Loeb E, McLellan A, Hill NO, Khan A. Clinical experience with DDP.In: Advances in antimicrobial and antineoplastic chemotherapy, vol II. Baltimore University Park Press, Baltimore, 1972; 255
12. Pinzani V, Bressolle F, Haug IJ, Galtier M, Blayac JP, Balmes P. Cis-platin-induced renal toxicity and toxicity-modulating strategies: a review. Cancer Chemother Pharmacol 1994; 35: 1-9
13. Meyer KB, Madias NE. Cis-platin nephrotoxicity. Miner Electrolyte Metab 1994; 20: 201-213
14. Wall E van der, Beijnen JH. Rodenhuis S. Antitumor treatment. High dose chemotherapy regimens for solid tumors. Cancer Treatment Rev 1995; 21: 105-132
15. Fjeldborg P, Sorensen J, Helkjacr PE. The long-term effect of cis-platin on renal function. Cancer 1985; 85: 2214-2219
16. Jacob SM, Arnold W, Marti HP. Progressive renal failure after cis-platin therapy. Nephrol Dial Transplant 1996; 11: 370-373
17. European Multicentre Transplant Study Group. Cyclosporine in cadaveric renal transplantation: one-year follow-up of a multicentre trial. Lancet 1983; 2: 986-989
18. Wheatley HC, Datzman M, Williams JW, Miles DE, Hatch FE. Long-term effects of cyclosporine on renal function in liver transplant recipients. Transplantation 1987; 43: 641-649
19. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclosporin-associated chronic nephropathy. New Engl J Med 1984; 311 699-705
20. Palestine AG, Austin III HA, Balow JE, Antonovych TT, Sabnis SG, Preuss HG. Nussenblatt RB. Renal histopathologic alterations in patients treated with cyclosporin for uveitis. New Engl J Med 1986; 314: 1293-1298
21. Myers BD, Sibley R, Newton L et al. The long-term course of cyclosporin-associated chronic nephropathy. Kidney Int 1988; 33: 590-600
22. Wallace HJ. Anderson-Fabry's disease. Br J Dermatol 1973; 88: 1-23
23. Pierides AM. Holti G, Crombie AL, Roberts DF, Gardiner SE, Colling A, Anderson J. Study on a family with Anderson-Fabry's disease and associated familial spastic paraplegia. J Med Genet 1976; 13: 455-461
24. Clarke JTR, Guttmann RD, Wolfe LS, Beaudoin JG, Morehouse DD. Enzyme replacement therapy by renal allotransplantation in Fabry's disease. New Engl J Med 1972; 287: 1215-1218
25. Desnick RJ, Simmons RL, Allen KY. Woods JE, Anderson CF, Najarian JS, Krivit W. Correction of enzymatic deficiencies by renal transplantation: Fabry's disease. Surgery 1972; 72: 203-211
26. Gantenbein H, Bruder E, Burger HR, Briner J, Binswanger U. Recurrence of Fabry's disease in a renal allograft 14 years after transplantation. Nephrol Dial Transplant 1995; 10: 287-289
27. Praet M, Quatacker J, Loo AV, Vanholder R, Lameire. Ringoir S. Non-invasive diagnosis of Fabry's disease by electronmicroscopic evaluation of urinary sediment. Nephrol Dial Transplant 1995; 10: 902-903
28. Nissenson AR, Port FK. Outcome of end-stage renal disease in patients with rare causes of renal failure. I. Inherited and metabolic disorders. Q J Med 1989; 73: 1055-106
29. Philippart M, Franklin SS, Gordon A. Reversal of an inborn sphingolipidosis (Fabry's disease) by kidney transplantation. Ann Intern Med 1972; 77: 195-200
30. Van der Bergh FAJTM, Rietra PJGM. Kolk-Vegter AJ, Bosch E, Tager JM. Therapeutic implications of renal transplantation in a patient with Fabry's disease. Acta Med Scand 1976; 200: 249-256
31. Spence MW, MacKinnon KE, Burgess JK, d'Entremont DM, Belitsky P, Lannon SG, MacDonald AS. Failure to correct the metabolic defect by renal allotransplantation in Fabry's disease. Ann Intern Med 1976; 84: 13-16
32. Maizel SE, Simmons RL, Kjellstrand C, Fryd DS. Ten-year experience in renal transplantation for Fabry's disease. Transplant Proc 1981; 13: 57-59
33. Farragiana T, Churg J. Grishman E et al. Light- and electronmicroscopic histochemistry of Fabry's disease. Am J Pathol 1981; 103: 247-262
34. Helin I. Fabry's disease. A brief review in connection with a Scandinavian survey. Scand J Urol Nephrol 1979; 13: 335-337
35. Bannwart F. Morbus Fabry; Licht- und elektronenmikrooskopischer herzbenfund 12 jahre nach erfolgreicher nierentransplantation. Schweiz Med Wschr 1982; 112: 1742-1747
36. Sheth KJ, Roth DA, Adams MB. Early renal failure in Fabry's disease. Am J Kidey Dis 1983; 2: 651-654
37. Kolodny HH. Case records Mass Gen Hospital. Case 2-1984. New Engl J Med. 1984: 106-114
38. Donati D, Novario R, Gastaldi L. Natural history and treatment of uremia secondary to Fabry's disease: a European experience. Nephron 1987; 46: 353-359
39. Donati D, Sabbadini MG, Capsoni F et al. Immune function and renal transplantation in Fabry's disease. Proc EDTA-ERA 1984; 21: 686-692
40. Friedlaender MM, Kopolovic J, Rubinger D et al. Renal biopsy in Fabry's disease eight years after successful renal transplantation. Clin Nephrol 1987; 27: 206-211.
41. Mosnier JF, Degott C, Bedrossian J et al. Recurrence of Fabry's disease in a renal allograft 11 years after successful renal transplantation. Transplantation 1991; 51: 759-762